Bank of America Issues Pessimistic Forecast for Abbott Laboratories (NYSE:ABT) Stock Price

Chronological Source Flow
Back

AI Fusion Summary

Bank of America cut Abbott Laboratories’ target from $150 to $120, rating, 23.85% upside; Freedom Capital upgraded, Raymond James lowered target to $130, outperform rating. National Bank Financial cut American Lithium’s target from C$0.95 to C$0.70, 9.37% upside; shares rose 4.9%.
19/04 08:34 defenseworld.net
6 Πηγές
19/04 08:40 defenseworld.net
19/04 09:08 defenseworld.net
19/04 09:17 defenseworld.net
19/04 09:18 defenseworld.net
19/04 09:36 defenseworld.net
Comments
Loading...
0